Stemmedicare

Stemmedicare appears to be an active life science/biotech healthcare company focusing primarily on novel extracellular vesicle-based therapies addressing multiple indications such as atopic dermatitis, osteoarthritis, cancer immunotherapy targeting tumor microenvironment modulation, neurodegenerative disorders via autophagy normalization through EV delivery across BBB, and infectious disease treatments including COVID19 applications. It uses innovative biologic modalities centered around EV technology platforms inducing regulatory T cells among other mechanisms. No detailed clinical trial results or published data were found specifically for "Stemmedicare." The website mentions therapeutic concepts but lacks published clinical trial phases or outcomes.